FI863120A - Nya (4-substituerad-piperazinyl) pyridaziner. - Google Patents

Nya (4-substituerad-piperazinyl) pyridaziner. Download PDF

Info

Publication number
FI863120A
FI863120A FI863120A FI863120A FI863120A FI 863120 A FI863120 A FI 863120A FI 863120 A FI863120 A FI 863120A FI 863120 A FI863120 A FI 863120A FI 863120 A FI863120 A FI 863120A
Authority
FI
Finland
Prior art keywords
pyridaziner
substituerad
nya
piperazinyl
Prior art date
Application number
FI863120A
Other languages
English (en)
Finnish (fi)
Other versions
FI863120A0 (fi
Inventor
Raymond A Stokbroekx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI863120A0 publication Critical patent/FI863120A0/fi
Publication of FI863120A publication Critical patent/FI863120A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI863120A 1985-07-31 1986-07-30 Nya (4-substituerad-piperazinyl) pyridaziner. FI863120A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76084585A 1985-07-31 1985-07-31

Publications (2)

Publication Number Publication Date
FI863120A0 FI863120A0 (fi) 1986-07-30
FI863120A true FI863120A (fi) 1987-02-01

Family

ID=25060338

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863120A FI863120A (fi) 1985-07-31 1986-07-30 Nya (4-substituerad-piperazinyl) pyridaziner.

Country Status (18)

Country Link
EP (1) EP0211457A3 (es)
JP (1) JPS6229575A (es)
KR (1) KR870001192A (es)
CN (1) CN86105558A (es)
AU (1) AU6073986A (es)
DK (1) DK363186A (es)
ES (1) ES8802151A1 (es)
FI (1) FI863120A (es)
GR (1) GR862022B (es)
HU (1) HU195501B (es)
IL (1) IL79549A0 (es)
NO (1) NO863083L (es)
NZ (1) NZ216918A (es)
PH (1) PH22884A (es)
PT (1) PT83098B (es)
TN (1) TNSN86117A1 (es)
ZA (1) ZA865700B (es)
ZW (1) ZW14886A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992433A (en) * 1987-11-23 1991-02-12 Janssen Pharmaceutica N.V. Novel pyridazinamine derivatives
MY104343A (en) * 1987-11-23 1994-03-31 Janssen Pharmaceutica Nv Novel pyridizinamine deravatives
US5070090A (en) * 1989-05-15 1991-12-03 Janssen Pharmaceutica N.V. Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines
US5270312A (en) * 1990-11-05 1993-12-14 Warner-Lambert Company Substituted piperazines as central nervous system agents
DE69842058D1 (de) 1997-10-27 2011-01-27 Neurosearch As Heteroaryl Diazacycloalkane als cholinergische Ligande für Nikotin-Acetylcholin-Rezeptoren
JP2002543070A (ja) 1999-04-26 2002-12-17 ニューロサーチ、アクティーゼルスカブ ヘテロアリールジアザシクロアルカン類、その製造方法及びその使用方法
EP1430033A4 (en) 2001-08-31 2004-12-15 Univ Northwestern PROTEIN KINASE ANTI-INFLAMMATORY AND INHIBITOR COMPOSITION AND METHOD OF USE
US7390813B1 (en) 2001-12-21 2008-06-24 Xenon Pharmaceuticals Inc. Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
US7754711B2 (en) 2003-07-30 2010-07-13 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
JP4808616B2 (ja) 2003-07-30 2011-11-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド ピリダジン誘導体および治療剤としてのその用途
US7759348B2 (en) 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
CN101712653A (zh) 2003-07-30 2010-05-26 泽农医药公司 哒嗪衍生物和它们作为治疗剂的用途
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
WO2006034315A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
WO2006034338A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
TW200624427A (en) 2004-09-20 2006-07-16 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CN101083994A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途
BRPI0515488A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de heterocìclicos e seu uso como agentes terapêuticos
MX2007005247A (es) 2004-11-02 2008-03-13 Univ Northwestern Compuestos de piridazina, composiciones y metodos.
AU2016203312B2 (en) * 2004-11-02 2018-05-24 Centre National De La Recherche Scientifique Pyridazine compounds, compositions and methods
EP1812007B1 (en) 2004-11-02 2011-09-07 Northwestern University Pyridazine compounds and methods
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
WO2007127474A2 (en) 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
WO2007127375A2 (en) 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
EP2148879B1 (en) 2007-04-23 2012-11-28 Janssen Pharmaceutica, N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
US8906921B2 (en) 2007-04-23 2014-12-09 Janssen Pharmaceutica Nv 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
JP5603770B2 (ja) * 2007-05-31 2014-10-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr2受容体拮抗薬およびその使用
EP2307374B1 (en) 2008-07-31 2017-01-25 Janssen Pharmaceutica NV Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
WO2012159662A1 (en) * 2011-05-24 2012-11-29 Universita' Degli Studi Di Bari New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
PL3317270T3 (pl) 2015-07-02 2020-11-16 Centrexion Therapeutics Corporation Cytrynian (4-((3r,4r)-3-metoksytetrahydropiran-4-yloamino)piperydyn-1-ylo)(5-metylo-6-(((2r,6s)-6-(p-tolilo)tetrahydro-2h-piran-2-ylo)metylamino)pirymidyn-4-ylo)metanonu

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines

Also Published As

Publication number Publication date
NZ216918A (en) 1988-11-29
ZA865700B (en) 1988-03-30
JPS6229575A (ja) 1987-02-07
ES8802151A1 (es) 1988-04-01
PH22884A (en) 1989-01-19
CN86105558A (zh) 1987-01-28
DK363186A (da) 1987-02-01
NO863083L (no) 1987-02-02
ZW14886A1 (en) 1988-02-24
DK363186D0 (da) 1986-07-30
EP0211457A3 (en) 1987-07-22
ES556738A0 (es) 1988-04-01
GR862022B (en) 1986-12-24
PT83098B (en) 1988-07-13
AU6073986A (en) 1987-02-05
IL79549A0 (en) 1986-10-31
HUT41772A (en) 1987-05-28
NO863083D0 (no) 1986-07-30
EP0211457A2 (en) 1987-02-25
KR870001192A (ko) 1987-03-12
TNSN86117A1 (fr) 1990-01-01
PT83098A (en) 1986-08-01
HU195501B (en) 1988-05-30
FI863120A0 (fi) 1986-07-30

Similar Documents

Publication Publication Date Title
FI864320A0 (fi) Nya foereningar.
FI861750A (fi) Nya foereningar.
FI864062A (fi) Nya acrylsyraamider.
FI863120A (fi) Nya (4-substituerad-piperazinyl) pyridaziner.
FI862801A (fi) Nya kemiska foereningar.
FI873977A (fi) Nya (1h-imidazol-1-ylmetyl) substituerande bensimidazolderivat.
FI864939A (fi) Nya kalcitoninderivator.
FI871540A (fi) Nya fluorpolymerloesningar.
FI863179A0 (fi) Nya benzamider.
FI863007A (fi) Nya kemiska foereningar.
FI862519A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara kinolonderivat.
FI863872A0 (fi) Nya piperazinkarboxiamider med en fenoxialkyl- eller tiofenoxialkylsidokedja.
FI862400A0 (fi) Foerfarande foer framstaellning av nya isatinkompositioner.
FI861681A (fi) Foerfarande foer framstaellning av nya 4-fenylpropyl-indolderivat.
FI865205A (fi) Nya herbicidiskt verksamma imidazolinoner.
FI864893A (fi) Foerfarande foer framstaellning av nya tetrahydroisokinolinderivat.
FI863742A0 (fi) Framstaellningsfoerfarande av nya catecolderivat.
FI863398A (fi) Foerfarande foer framstaellning av nya hydropyridinderivat.
FI861414A (fi) Foerfarande foer framstaellning av nya bensoesyraderivat.
FI862679A0 (fi) Nya foereningar.
FI870091A (fi) Nya biocider.
FI851289A0 (fi) Nya r-timololmellanprodukter.
FI854106L (fi) Foerfarande foer framstaellning av nya fluorerade resorcinetrar.
FI873365A0 (fi) Foerfarande foer framstaellning av nya fosfo-foereningar.
FI900007A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-aminoalkyl-b-karbolinderivat.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: JANSSEN PHARMACEUTICA N.V.